🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

29 recruiting trials

for Tuberculosis, Latent

Training Protocol on the Natural History of Tuberculosis NCT01212003n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Testing Health Workers At Risk to Advance Our Understanding of TB Infection NCT06221488n/a1 site📍 Cape Town Beth Israel Deaconess Medical Center · Tests: TB infection testing Lung Innate Immunity and Microbiome After Tuberculosis Exposure NCT06526689n/a3 sites📍 Oxford📍 Oxford📍 London University of Oxford Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age NCT06289660n/a17 sites📍 Florence📍 Bari📍 Belluno Meyer Children's Hospital IRCCS Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention NCT06281834Phase 11 site📍 Ibadan Brigham and Women's Hospital · Tests: Rifapentine, Dolutegravir Screening With Portable X-rays for Rapid Recognition of TB NCT07737275NA1 site📍 New York Columbia University · Tests: Mobile chest radiography for tuberculosis screening Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure) NCT07164742NA2 sites📍 Mangalore📍 Pune Johns Hopkins University · Tests: 8 week (short arm) Intervention - pulmonary rehabilitation, 24 week (long arm) Intervention - pulmonary rehabilitation Window Prophylaxis for Pediatric Tuberculosis Prevention Trial NCT07086820NA13 sites📍 Calama📍 Coquimbo📍 La Serena Pontificia Universidad Catolica de Chile · Tests: Tuberculosis window prophylaxis with weekly rifapentine and isoniazid for 12 weeks, Standard of care tuberculosis proph… Diagnosis of Tuberculosis in Swiss Children NCT03044509n/a8 sites📍 Aarau📍 Basel📍 Bellinzona University Children's Hospital Basel · Tests: Secreted cytokine assay, Intracellular cytokine assay ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients NCT06796647n/a2 sites📍 Hong Kong📍 Shatin Chinese University of Hong Kong · Tests: ESAT6/CFP10 skin test Latent Infection Freshmen Tracking for Tuberculosis NCT07811518Phase 42 sites📍 Nantong📍 Meishan Affiliated Hospital of Nantong University · Tests: tuberculosis preventive treatment Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis NCT06764576n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students NCT05756582n/a1 site📍 Roma Eleonora Nucera · Tests: Prevalence of Latent Tuberculosis Infection Economic Incentives and vDOT for Latent Tuberculosis Infection NCT05022862NA1 site📍 Baltimore Johns Hopkins University · Tests: Usual Care, Video Directly Observed Therapy alone, Video Directly Observed Therapy plus Financial Incentives Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis NCT06485895NA1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: test IGRA, TEST QUATIFERON TB Gold Plus Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients NCT06033807n/a44 sites📍 Zunyi📍 Bijie📍 Bijie Huashan Hospital · Tests: QuantiFERON-TB Gold (QFT) test Seoul National University Airway Registry NCT02527486n/a3 sites📍 Seongnam-si📍 Seoul📍 Seoul Seoul National University Hospital BPaLMZ for TB Meningitis NCT07227779Phase 22 sites📍 Kampala📍 Mbarara David Boulware · Tests: BPaLMZ Regimen Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI NCT03474029Phase 2, Phase 321 sites📍 Denver📍 Washington D.C.📍 Washington D.C. Centers for Disease Control and Prevention · Tests: Rifapentine daily for 6 weeks, Rifapentine and Isoniazid weekly for 12 weeks, Rifampin and Isoniazid daily for 12 weeks… Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB NCT06568484Phase 2, Phase 38 sites📍 Ulaanbaatar📍 Lima📍 Lima Johns Hopkins University · Tests: Bedaquiline, Isoniazid, rifapentine, Levofloxacin Effects of Tuberculosis Infection on Development and Function of the Placenta NCT06352970n/a1 site📍 Addis Ababa Lund University · Tests: TB infection The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study NCT05588492Phase 41 site📍 Taipei National Taiwan University Hospital · Tests: Rifamycin-containing regimen, Rifamycin-free regimen A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV NCT07124559Phase 1, Phase 211 sites📍 Gaborone📍 Molepolole📍 Port-au-Prince National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Rifapentine, Isoniazid, Dolutegravir Shorter and Safer Treatment Regimens for Latent TB NCT06498414Phase 2, Phase 314 sites📍 Cotonou📍 Manaus📍 Calgary McGill University Health Centre/Research Institute of the M… · Tests: rifampin standard arm, rifampin double dose, levofloxacin and rifapentine A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study) NCT06022146Phase 366 sites📍 Anshun📍 Anshun📍 Anshun Huashan Hospital · Tests: isoniazid and rifapentine, Rifampin and Isoniazid A Systemic Screening for TB Disease in High-risk Groups in Barcelona NCT06706596n/a1 site📍 Badalona Fundació Institut Germans Trias i Pujol · Tests: Screening for TB symptoms, Chest X-ray PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment NCT07024836n/a1 site📍 London University College, London Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin NCT05069688Phase 11 site📍 Ibadan Brigham and Women's Hospital · Tests: rifampicin Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis NCT04700579n/a3 sites📍 Cape Town📍 Cape Town📍 Cape Town University of Stellenbosch
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy